| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.8M | -1.3% | -1.2% |
| Cost of Revenue | $25.2M | -5.0% | -30.8% |
| R&D Expense | $4.5M | -7.7% | -4.2% |
| SG&A Expense | $10.5M | -10.1% | +8.0% |
| Operating Income | -$28.1M | -5.6% | +14.2% |
| Pre-tax Income | -$16.3M | +46.2% | +48.6% |
| Income Tax | $31K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $269.8M | -5.0% | +106.3% |
| Accounts Receivable | $12.6M | -2.1% | +11.2% |
| Current Assets | $287.1M | -4.7% | +80.7% |
| Total Assets | $367.2M | -3.4% | +69.1% |
| Current Liabilities | $47.5M | +21.6% | +17.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.0M | — | — |
| Capital Expenditures | $1.8M | — | — |
| Investing Cash Flow | -$22.9M | — | — |
| Financing Cash Flow | $219.6M | — | — |
| Free Cash Flow | -$42.8M | — | — |
| — |
| +136.8% |
| Net Income | -$16.3M | +46.2% | +48.4% |
| EPS (Basic) | -$0.06 | +50.0% | +60.0% |
| EPS (Diluted) | -$0.06 | +50.0% | +60.0% |
| $64.9M |
| -1.2% |
| +27.2% |
| Stockholders' Equity | $302.2M | -3.8% | +81.9% |